Theralase Technologies Inc. V.TLT

Forecast

[Alamir1111]

New interim clinical data has Research Capital Corporation analyst Andr Uddin feeling more bullish about Canadian drug developer Theralase Technologies (Theralase Technologies Stock Quote, Charts, News, Analysts, Financials TSXV:TLT). Uddin maintained a “Speculative Buy” rating while raising his target price from $0.70/share to $1.20/share for a projected return of 161 per cent in an update to clients on TuesdayHe also expects 2022 ($907,000) and 2023 ($998,000) to come in below the $1 million mark in terms of revenue, but he forecasts 2024 to be a major year, with the forecasted launch of TLD-1433 sales expected to fuel a rise to $30.9 million in revenue, the start of a growth ramp that Uddin forecasts to reach $255 million by 2030, almost entirely fuelled by continued TLD-1433 sales.

[Alamir1111]

I guess Mp got his 300% upside from this article

[Alamir1111]

Would love to smoke the sh he does

[Kayz88]

Published in 2022

[Alamir1111]

Yes you are right Here is a 2023 oneHe reiterated a “speculative buy” rating for Theralase, with a price target of 80 cents. At mid-day on May 31, the stock was quoted at 24.5 cents.

[Alamir1111]

Not bad 4% in 20 months quite an achievment

[Alamir1111]

This is the time I when I first invested in co 2015 the Company is in the final steps of completing the research and development of its patented and patent pending anti-cancer technology allowing enrollment of patients in a Phase Ib human clinical trial for the treatment of NMIBC in 4Q2015.”   Mr. Dumoulin-White concluded that, “The Company is confident that the successful execution of

[Feedman2980]

Mr. Dumoulin-White concluded that, “The Company is confident that the successful execution of these strategic initiatives will dramatically increase shareholder value.” Time to bring it home Roger. We want to go to Vegas, not The Villages. 

[riverrrow]

Looks like his forecast for TLT for 2024 was wrong.  It's no wonder clients at Research Capital don't seem to be big buyers of TLT.